Patents by Inventor Mark G. Saifer

Mark G. Saifer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030012777
    Abstract: Methods are provided for the stabilization of proteinases by the covalent attachment of or admixture with water-soluble polymers. The resultant stabilized proteinases have increased stability under the harsh conditions used in industrial genomics, which permits their use in the extraction and isolation of nucleic acids and the identification of disease-related prion proteins at elevated temperatures in solutions containing chaotropic agents, such as sodium dodecyl sulfate, urea or guanidinium salts, conferring advantages for robotic applications.
    Type: Application
    Filed: June 28, 2002
    Publication date: January 16, 2003
    Inventors: Merry R. Sherman, Alexa L. Martinez, Shyam S. Bhaskaran, L. David Williams, Mark G. Saifer, John A. French
  • Patent number: 4070459
    Abstract: N-carbamylated orgotein, like the native protein, possesses superoxide dismutase and anti-inflammatory activity.
    Type: Grant
    Filed: December 9, 1975
    Date of Patent: January 24, 1978
    Assignee: Diagnostic Data, Inc.
    Inventors: Wolfgang Huber, Mark G. Saifer, Lewis D. Williams
  • Patent number: 4042689
    Abstract: N-alkylated orgotein, like the native protein, possesses superoxide dismutase and anti-inflammatory activity.
    Type: Grant
    Filed: September 9, 1975
    Date of Patent: August 16, 1977
    Assignee: Diagnostic Data, Inc.
    Inventors: Wolfgang Huber, Mark G. Saifer, Lewis D. Williams
  • Patent number: 4022224
    Abstract: The toxic effects of smoke inhalation are reduced by the inhalation of an amount of orgotein effective to reduce the amount of superoxide radicals produced in the respiratory tract by the smoke.
    Type: Grant
    Filed: September 9, 1975
    Date of Patent: May 10, 1977
    Assignee: Diagnostic Data, Inc.
    Inventors: Mark G. Saifer, Lewis D. Williams, Wolfgang Huber
  • Patent number: 4022888
    Abstract: Esterified orgotein, like the native protein, possesses Superoxide Dismutase and anti-inflammatory activity.
    Type: Grant
    Filed: September 9, 1975
    Date of Patent: May 10, 1977
    Assignee: Diagnostic Data, Inc.
    Inventors: Wolfgang Huber, Mark G. Saifer, Lewis D. Williams
  • Patent number: 4022877
    Abstract: Orgotein labeled with .sup.99M Tc, or with a radioactive iodine isotope, preferably .sup.131 I, is useful in scintigraphy for tissue visualization, especially the kidneys.
    Type: Grant
    Filed: September 9, 1975
    Date of Patent: May 10, 1977
    Assignee: Diagnostic Data, Inc.
    Inventors: Wolfgang Huber, Mark G. Saifer, Lewis D. Williams
  • Patent number: 4017605
    Abstract: N-acylated orgotein, although possessing substantially less SODase activity than the native protein, possesses antiinflammatory activity comparable to that of orgotein.
    Type: Grant
    Filed: September 20, 1974
    Date of Patent: April 12, 1977
    Assignee: Diagnostic Data, Inc.
    Inventors: Wolfgang Huber, Mark G. Saifer, Lewis D. Williams
  • Patent number: 4009267
    Abstract: Orgotein cross-linked with itself or with non-antigenic injectable serum or tissue protein has a substantially longer half-life in the blood after injection than orgotein.
    Type: Grant
    Filed: September 9, 1975
    Date of Patent: February 22, 1977
    Assignee: Diagnostic Data, Inc.
    Inventors: Wolfgang Huber, Mark G. Saifer, Lewis D. Williams